Jichuan Pharmaceuticals: Discloses the results of Cao Fei's tender offer for acquisition, stock will resume trading on the 21st.
On the evening of July 20, Jichuan Pharmaceuticals announced that previously, Cao Fei had issued a comprehensive offer to acquire all unrestricted tradable shares of the company from shareholders other than Cao Longxiang, Jichuan Holdings, and Jichuan Tibet. As of July 17, the offer period had expired, with a total of 34 shareholders accepting the offer, holding a total of 16,300 shares, accounting for 0.0018% of the total share capital of the company. Cao Fei will purchase the shares according to the agreed conditions. After the completion of the offer, Cao Fei and its concerted action person Cao Longxiang will jointly control 61.15% of the company's shares. The company's stock will resume trading on July 21.
Latest